STLN Starling Oncology, Inc.
Nasdaq · SEC CIK 1799191 · EDGAR
- Bought, last 12 months
- $2.69M 13 purchases by 1 insiders
- Sold, last 12 months
- $2.81M 7 sales by 5 insiders
- Filings on record
- 228 since 2021-11-16, latest 2026-08-24 17:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chernett Jorey | 10% | $2.69M | — |
| Hively Brad | Dir | — | $2.00M |
| Kaushal Mohit | Dir | — | $335.1K |
| Podnos Yale | Chief Medical Off | — | $276.4K |
| Pacala Mark L | Dir | — | $200.0K |
| Carter Robert Ross | CFO | — | $879.32 |
| England Kristin | Chief Administrative Off | — | — |
| Langsam Jeffrey | Chief Clinical Off | — | — |
| Ling Gabriel | Dir | — | — |
| TOI M, LLC | Dir | — | — |
Transactions 242
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-29 | 2022-09-27+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $4.67 | -47.7K | 14.67M | -0.3% | -$222.7K |
| MI | 2022-09-26 | 2022-09-22+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $4.33 | -25.6K | 14.70M | -0.2% | -$110.8K |
| MI | 2022-09-19 | 2022-09-15+ | STLN | Havencrest Healthcare Partners GP, LLC | 10% | S - Sale | $4.50 | -288.1K | 14.71M | -2% | -$1.30M |
| MI | 2022-09-14 | 2022-09-12+ | STLN | TOI HC I, LLC | 10% | S - Sale | $5.27 | -128.3K | 15.04M | -0.8% | -$675.5K |
| MI | 2022-09-09 | 2022-09-07+ | STLN | TOI HC I, LLC | 10% | S - Sale | $5.99 | -87.4K | 15.13M | -0.6% | -$523.4K |
| MI | 2022-09-06 | 2022-09-01+ | STLN | TOI HC I, LLC | 10% | S - Sale | $5.99 | -157.5K | 15.34M | -1% | -$943.6K |
| MI | 2022-08-31 | 2022-08-29+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $6.23 | -78.5K | 15.40M | -0.5% | -$489.4K |
| MI | 2022-08-26 | 2022-08-24+ | STLN | TOI HC I, LLC | 10% | S - Sale | $6.15 | -64.6K | 15.49M | -0.4% | -$397.4K |
| MI | 2022-08-23 | 2022-08-19+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $6.57 | -94.5K | 15.52M | -0.6% | -$620.4K |
| MI | 2022-08-16 | 2022-08-12+ | STLN | TOI HC I, LLC | 10% | S - Sale | $6.49 | -50.0K | 15.61M | -0.3% | -$324.4K |
| D | 2022-05-19 | 2022-05-19 | STLN | Shah Mihir | CFO | A - Grant | $0.00 | +32.1K | 32.1K | New | $0 |
| MI | 2022-05-13 | 2022-05-11 | STLN | Jimmy Holdings, Inc. | 10% | S - Sale | $6.00 | -1.60M | 253.4K | -86% | -$9.60M |
| DM | 2022-03-23 | 2022-03-21 | STLN | Miller Matthew P | COO | A - Grant | $0.00 | +28.0K | 78.6K | +55% | $0 |
| M | 2022-03-23 | 2022-03-21 | STLN | SARIN RAVI YANG | Dir | A - Grant | $0.00 | +23.2K | 23.2K | New | $0 |
| M | 2022-03-23 | 2022-03-21 | STLN | O'Meara Maeve | Dir | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2022-03-23 | 2022-03-21 | STLN | Virnich Daniel | Pres | A - Grant | $0.00 | +42.0K | 237.3K | +22% | $0 |
| M | 2022-03-23 | 2022-03-21 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +20.8K | 41.5K | +100% | $0 |
| M | 2022-03-23 | 2022-03-21 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +22.4K | 22.4K | New | $0 |
| DM | 2022-03-23 | 2022-03-21 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +14.9K | 43.3K | +52% | $0 |
| D | 2022-03-23 | 2022-03-21 | STLN | Hively Brad | CEO, Dir | A - Grant | $0.00 | +108.5K | 461.9K | +31% | $0 |
| D | 2022-03-23 | 2022-03-21 | STLN | Dalgleish Scott | CFO | A - Grant | $0.00 | +32.1K | 151.0K | +27% | $0 |
| 2022-03-23 | 2022-03-21 | STLN | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +45.9K | 142.0K | +48% | $0 | |
| M | 2022-03-23 | 2022-03-21 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +20.8K | 20.8K | New | $0 |
| M | 2021-11-24 | 2021-11-24 | STLN | BARASCH RICHARD A | Dir | P - Purchase | $6.92 | +5,000 | 96.1K | +5% | +$34.6K |
| M | 2021-11-24 | 2021-11-23 | STLN | BARASCH RICHARD A | Dir | P - Purchase | $6.34 | +5,000 | 91.1K | +6% | +$31.7K |
| DAI | 2021-11-22 | 2021-11-12 | STLN | SARIN RAVI YANG | Dir | A - Grant | — | +4.11M | 4.11M | New | — |
| DA | 2021-11-18 | 2021-11-12 | STLN | BARASCH RICHARD A | Dir | D - Sale to Iss | — | -14.9K | 85.1K | -15% | — |
| DA | 2021-11-18 | 2021-11-12 | STLN | BARASCH RICHARD A | Dir | M - OptEx | — | +100.0K | 100.0K | New | — |
| 2021-11-18 | 2021-11-16 | STLN | BARASCH RICHARD A | Dir | P - Purchase | $10.12 | +1,000 | 86.1K | +1% | +$10.1K | |
| MA | 2021-11-18 | 2021-11-12 | STLN | Hively Brad | CEO, Dir | A - Grant | $0.00 | +353.4K | 363.4K | +3,534% | $0 |
| DA | 2021-11-18 | 2021-11-12 | STLN | Kaushal Mohit | Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| DM | 2021-11-16 | 2021-11-12 | STLN | Dalgleish Scott | CFO | A - Grant | $0.00 | +118.9K | 47.6K | New | $0 |
| DM | 2021-11-16 | 2021-11-12 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +28.4K | 11.4K | New | $0 |
| DM | 2021-11-16 | 2021-11-12 | STLN | Virnich Daniel | COO | A - Grant | $0.00 | +195.2K | 195.2K | New | $0 |
| DMI | 2021-11-16 | 2021-11-12 | STLN | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10%, Possible Members of 10% Group | C - Cnv Deriv | — | +85.2K | 85.1K | New | — |
| D | 2021-11-16 | 2021-11-12 | STLN | Kaushal Mohit | Dir | C - Cnv Deriv | — | +30.0K | 30.0K | New | — |
| D | 2021-11-16 | 2021-11-12 | STLN | Kaushal Mohit | Dir | D - Sale to Iss | — | -4,466 | 25.5K | -15% | — |
| I | 2021-11-16 | 2021-11-12 | STLN | OncologyCare Partners, LLC | Dir | A - Grant | $0.00 | +4.11M | 4.11M | New | $0 |
| D | 2021-11-16 | 2021-11-12 | STLN | HOCHBERG STEVEN | 10%, Possible Members of 10% Group | C - Cnv Deriv | — | +40 | 40 | New | — |
| DM | 2021-11-16 | 2021-01-12 | STLN | Hively Brad | CEO, Dir | A - Grant | $0.00 | +353.4K | 141.4K | New | $0 |
| D | 2021-11-16 | 2021-11-12 | STLN | BARASCH RICHARD A | Dir | D - Sale to Iss | — | -14.9K | 85.1K | -15% | — |
| D | 2021-11-16 | 2021-11-12 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | — | +100.0K | 100.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations